Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (628,348)	$ (557,307)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	96	4,489
Loss on sale of marketable securities	60,143
Change in assets and liabilities:
Royalty receivables	78,086	(139,578)
Prepaid expenses and other current assets	6,358	(28,759)
Accounts payable and accrued expenses	(25,045)	50,550
Deferred revenue	10,756	27,945
Net cash used in operating activities	(497,954)	(642,660)
Cash flows from investing activities:
Purchases of fixed assets	(605)	(346)
Proceeds from sales of marketable securities	2,694,968
Net cash provided by (used in) investing activities	2,694,363	(346)
Cash flows from financing activities:
Proceeds from exercise of options		86,262
Net cash provided by financing activities		86,262
Net increase (decrease) in cash and cash equivalents	2,196,409	(556,744)
Cash and cash equivalents at beginning of period	269,964	4,772,705
Cash and cash equivalents at end of period	$ 2,466,373	$ 4,215,961